Krassimir Mitchev

Statistics

Publications

Citations

487

H-Index

Active since

2002

Affiliations

UCB Pharma (Belgium)(Current)

Imelda Hospital

Centre Hospitalier Universitaire de Lille

University of Miami

University of Alberta

Krassimir Mitchev is an author at UCB Pharma (Belgium) specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and crohn disease pharmacotherapy.

Publications per year

2002–2012

Publications

Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol

Xavier Hébuterne, Marc Lémann, Yoram Bouhnik et al. · Gut · 2012 · 167 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab

William J. Sandborn, María T. Abreu, Geert D’Haens et al. · Clinical Gastroenterology and Hepatology · 2010 · 152 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

`Black Spots' and Hyaline Pleural Plaques on the Parietal Pleura of 150 Urban Necropsy Cases

Krassimir Mitchev, Pascal Dumortier, Paul De Vuyst · The American Journal of Surgical Pathology · 2002 · 61 citations

Medicine, Anatomy, Pathology +14

Non-Interventional Study Comparing Treatment Satisfaction in Patients Treated with Antihistamines

Christine De Vos, Krassimir Mitchev, Marie-Etienne Pinelli et al. · Clinical Drug Investigation · 2008 · 34 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

494 Efficacy and Safety of Certolizumab Pegol in Patients with Active Crohn's Disease Who Previously Lost Response or Were Intolerant to Infliximab: Open-Label Induction Preliminary Results of the Welcome Study

Séverine Vermeire, María T. Abreu, Geert D’Haens et al. · Gastroenterology · 2008 · 25 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

1–5 of 8